Macrocyclic peptide immuno-oncology therapeutic

N/A

Report date: 2023/03/05 16:37:43
NME

Base Information

Drug NameMacrocyclic peptide immuno-oncology therapeutic
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionProtein interaction domain and motifs inhibitors
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A